Harness Biotech Volatility with an Options Strategy
Dec 08th, 2015
Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim
December 8th 2015
Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That’s the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can you grow a portfolio if some of your more successful names are called away by option buyers before the stock goes into the stratosphere? The answer is yes, and in this interview with The Life Sciences Report, Rahim describes his technique and leaves readers with six names that he fully expects to reap very large gains.